Gamma-oryzanol is a mixture of ferulate esters of sterols and triterpene alcohols. The lipid-lowering mechanism involves: (1) ferulic acid inhibiting HMG-CoA reductase (mild statin-like effect); (2) reducing intestinal cholesterol absorption by inhibiting cholesterol esterase; (3) upregulating hepatic LDL receptor expression, increasing LDL clearance. For menopause, it modulates the hypothalamic-pituitary axis — specifically reducing LH surges that trigger hot flashes — without direct estrogenic activity (not a phytoestrogen). It also has gastric mucosal protective effects via increased prostaglandin E2 synthesis.
No critical interactions identified.
Independently graded against 173,636 indexed supplements with 177 published clinical interactions, sourced from PubMed, FDA CAERS, openFDA, and NIH DSLD | Last updated:
Not medical advice. Based on published clinical research and systematic reviews.